Quanterix (QTRX) vs Seer (SEER)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Seer (SEER) has outperformed Quanterix (QTRX) over the past year, losing 3.6% versus a loss of 46.5%. Over five years, SEER leads with a -93.4% price change compared with -93.8% for QTRX. Quanterix is the larger company by market cap ($151.8 million vs $120.2 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | QTRX | SEER |
|---|---|---|
| Share price | $3.21 | $2.17 |
| Market cap | $151.81M | $120.16M |
| 1-day change | -3.46% | -1.81% |
| YTD return | -49.53% | +18.58% |
| 1-year return | -46.50% | -3.56% |
| 5-year return | -93.79% | -93.42% |
| EPS (TTM) | $-2.61 | $-1.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.77 | $2.41 |
| 52-week low | $2.15 | $1.55 |
| Distance from 52-week high | -63.40% | -9.96% |
| Analyst consensus | none | none |
| Avg. price target upside | -6.54% | +84.33% |
| Average volume | 762.14K | 479.14K |
| Shares outstanding | 47.29M | 55.37M |
| Employees | 450 | 124 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SEER has outperformed QTRX by 42.9 percentage points over the past year.
About Quanterix
QTRX stock →Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
Industrials · Biotechnology: Laboratory Analytical Instruments · 450 employees
About Seer
SEER stock →Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.
Industrials · Biotechnology: Laboratory Analytical Instruments · 124 employees
QTRX vs SEER FAQ
Which is bigger, Quanterix or Seer?
Quanterix (QTRX) is larger, with a market capitalization of $151.81M compared with $120.16M for Seer (SEER).
Which stock has performed better over the past year, QTRX or SEER?
SEER returned -3.56% over the past 12 months, compared with -46.50% for QTRX (price return, excluding dividends). Past performance does not predict future results.
Are Quanterix and Seer in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.